NEWARK, Del, May 25, 2023 (GLOBE NEWSWIRE) -- The Hypoparathyroidism Treatment Market was estimated to be worth US$ 777.4 million in 2022 and is anticipated to grow to US$ 841.9 million in 2023. The market is anticipated to grow at a CAGR of 7.7% from 2023 to 2033, reaching a projected value of US$ 1,767.4 million at the end of the forecast period. The Hypoparathyroidism Treatment Market will expand positively, with total revenue expected to exceed US$ 777.4 million by 2022. The market for Hypoparathyroidism Treatments is expected to increase at a 7.7% CAGR by volume (units).
Around 200, 000 persons are affected by hypoparathyroidism, with the majority of instances being connected with inadvertent injury or removal of the parathyroid gland during thyroid surgery. Other occurrences are linked to autoimmune, genetic, or idiopathic conditions. The current standard of care includes the administration of calcium and vitamin D analogues (Vitamins D2 and D3).
Get a PDF Sample with the Latest Market Insights @ https://www.futuremarketinsights.com/reports/sample/rep-gb-7857
On the contrary hand, hormonal therapy is gaining popularity as a first treatment in patients with severe hypoparathyroidism. The possible dangers linked with developing osteosarcoma have reduced adoption rates. Long-term goals, however, are concentrating market makers on spending heavily on the development of safe and effective hormone medicines.
Key Takeaways:
- Over the next several decades, the Indian market is expected to grow at an 8.6% CAGR.
- By 2033, the worldwide market is expected to be worth US$ 1767.4 million.
- The United States has emerged as the dominant market, accounting for more than 37.7% of overall demand in 2022.
- Over the next several decades, the Chinese market is expected to grow at a CAGR of 7.9%.
- In 2022, the calcium supplements category accounted for 38.29% of market revenue.
“As patient awareness grows, the market is projected to see a rise in patient screening for a variety of thyroid diseases. Furthermore, the approval and classification of hypothyroidism medications as orphan pharmaceuticals by the US Food and Drug Administration (FDA) and the European Commission (EC), along with the untapped patient pool, is projected to boost market development,” - says an analyst at FMI.
Resolve your queries from our Market Research Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-7857
Competitive Landscape:
- Amolyt Pharma revealed an oral presentation at the 25th European Congress of Endocrinology (ECE) 2023 in May 2023. The presentation highlights the potential benefits of eneboparatide as a treatment for hypoparathyroidism, an illness in which numerous individuals have or are at risk of developing osteopenia and osteoporosis.
- In November 2022, the Food and Drug Administration (FDA) authorized for Priority Assessment a new drug application (NDA) for TransConTM PTH (palopegteriparatide) in adults with hypoparathyroidism.
More Valuable Insights:
Future Market Insights (FMI), in its new offering, presents an unbiased analysis of the Global Hypoparathyroidism Treatment market presenting a historical analysis from 2018 to 2022 and forecast statistics for the period of 2023 to 2033.
The study reveals essential insights by Product Type (Parathyroid Hormone, Vitamin D Analogue, Calcium Supplements), Route of Administration (Oral, Parenteral), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Sales) & Region.
Key Companies Profiled:
- Takeda Pharmaceutical Company Limited.
- Entera Bio Ltd.
- Amgen Inc.
- Ascendis Pharma A/S
- F. Hoffmann-La Roche Ltd
- ProLynx, Inc.
- Extend Biosciences, Inc.
- BionPharma Inc.
- Teva Pharmaceuticals Ltd.
For more Report Customization, connect with us at https://www.futuremarketinsights.com/customization-available/rep-gb-7857
Market Segmentation:
By Product Type:
- Parathyroid Hormone
- Natpara
- Others
- Vitamin D Analogue
- Vitamin D2
- Vitamin D3
- Calcium Supplements
By Route of Administration:
- Oral
- Parenteral
By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Sales
By Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- Middle East & Africa
Interested in buying this report – now get this at a 20% discount
Table of Content (ToC):
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product Type
Get your complete TOC of this Report with figures @ https://www.futuremarketinsights.com/toc/rep-gb-7857
About the Technology Division at Future Market Insights (FMI):
The Healthcare team at Future Market Insights offers expert analysis, time-efficient research, and strategic recommendations with the objective to provide authentic insights and accurate results to help clients worldwide. With a repertoire of over 100+ reports and 1 million+ data points, the team has been analyzing the industry lucidly in 50+ countries for over a decade. The team provides a brief analysis of key trends including competitive landscape, profit margin, and research development efforts
Explore FMI’s related ongoing Coverage in Healthcare Market Domain:
Digital Psychotherapeutics Market Size The global digital psychotherapeutics market size is projected to be worth US$ 1.06 billion in 2023. Over the next ten years, global digital psychotherapeutics demand is likely to accelerate at 27.6% CAGR. By 2033, the total market value is expected to surpass US$ 12.2 billion.
Clinical Research Organization Market Share According to Future Market Insights (FMI) analysis in a recent market survey, the global clinical research organization market was valued at US$ 58.0 Billion in 2022 and is expected to reach US$ 139.6 Billion by 2033.
Mastectomy Reconstruction Implants Market Demand According to Future Market Insights (FMI) analysis in a recent market survey, the global mastectomy reconstruction implants market was valued at US$ 1.95 Billion in 2022 and is set to reach US$ 4.69 Billion by 2033.
Pulmonology Devices Market Opportunity The global pulmonology devices market is estimated at US$ 1.4 billion in 2023. The market is projected to reach US$ 3.8 billion by 2033, exhibiting a CAGR of 10.3% from 2023 to 2033.
Esophageal Implant Market Growth: The global esophageal implant market size is estimated to reach US$ 147.0 million in 2023. From 2023 to 2033, global esophageal implant sales are projected to soar at 6.7% CAGR. By the end of 2033, the total market value is likely to exceed US$ 280.2 million.
Synchrotron Instrumentation Market Analysis According to Future Market Insights research, during the projected period, the global synchrotron instrumentation market is expected to grow at a CAGR of 5.6%. The market value is projected to increase from US$ 1.05 Billion in 2023 to US$ 1.80 Billion by 2033.
Robotic Lung Biopsy Market Development The robotic lung biopsy market size is projected to be worth US$ 408.0 million in 2023. From 2023 to 2033, global robotic lung biopsy demand is forecast to rise at 9.6% CAGR. Total market valuation at the end of 2033 is expected to surpass US$ 1,023.05 million.
Dermatology Excimer Lasers Market Trends According to Future Market Insights research, during the projected period, the global dermatology excimer lasers market is expected to grow at a CAGR of 11.4%. The market value is projected to increase from US$ 87.7 Million in 2023 to US$ 258.4 Million by 2033.
Image Guided Systems Market Strategies The Global Image Guided Systems Market was valued at US$ 7.23 Billion in 2022 and is expected to reach US$ 17.41 Billion by 2033. The devices segment with a market share of more than 75% has topped the global market within the product category and is expected to grow at a CAGR of close to 8.2% over the forecast period (2023 to 2033).
Dental Crown Removal Market Outlook: The dental crown removal market is estimated to secure a valuation of US$ 294.59 million in 2023 and is predicted to reach US$ 461.9 million by 2033. The market is capturing a CAGR of 4.6% during the forecast period.
About Future Market Insights (FMI):
Future Market Insights, Inc. (ESOMAR certified, Stevie Award - recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10 years.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn | Twitter | Blogs
